{
    "zip": "KY1-1108",
    "sector": "Healthcare",
    "fullTimeEmployees": 7600,
    "longBusinessSummary": "BeiGene, Ltd. discovers, develops, manufactures, and commercializes medicines for cancer therapeutics in the People's Republic of China and the United States. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; ABRAXANE to treat breast cancer; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and BAT1706 to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. BeiGene, Ltd. has a strategic collaboration with Shoreline Biosciences, Inc. to develop and commercialize a portfolio of NK-based cell therapeutics. The company was incorporated in 2010 and is based in Grand Cayman, Cayman Islands.",
    "city": "Grand Cayman",
    "country": "Cayman Islands",
    "companyOfficers": [],
    "website": "https://www.beigene.com",
    "maxAge": 1,
    "address1": "94 Solaris Avenue",
    "industry": "Biotechnology",
    "address2": "Camana Bay",
    "ebitdaMargins": -1.23407,
    "profitMargins": -1.2240599,
    "grossMargins": -0.43234003,
    "operatingCashflow": -1123218048,
    "revenueGrowth": 1.267,
    "operatingMargins": -1.2725,
    "ebitda": -1311076992,
    "targetLowPrice": 293.28,
    "recommendationKey": "buy",
    "grossProfits": -1056660000,
    "freeCashflow": -812382976,
    "targetMedianPrice": 419.7,
    "currentPrice": 225.34,
    "earningsGrowth": null,
    "currentRatio": 3.398,
    "returnOnAssets": -0.15571,
    "numberOfAnalystOpinions": 14,
    "targetMeanPrice": 421.58,
    "debtToEquity": 20.838,
    "returnOnEquity": -0.3398,
    "targetHighPrice": 509.6,
    "totalCash": 3916926976,
    "totalDebt": 699534976,
    "totalRevenue": 1062403968,
    "totalCashPerShare": 41.747,
    "financialCurrency": "USD",
    "revenuePerShare": 11.58,
    "quickRatio": 3.128,
    "recommendationMean": 2,
    "exchange": "NMS",
    "shortName": "BeiGene, Ltd.",
    "longName": "BeiGene, Ltd.",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EST",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-18000000",
    "underlyingSymbol": null,
    "quoteType": "EQUITY",
    "symbol": "BGNE",
    "underlyingExchangeSymbol": null,
    "headSymbol": null,
    "messageBoardId": "finmb_115205344",
    "uuid": "fa34b256-867c-3115-a0ac-dc5f85107a4b",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 18.716,
    "beta3Year": null,
    "enterpriseToEbitda": -15.166,
    "52WeekChange": null,
    "morningStarRiskRating": null,
    "forwardEps": -13.53,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 102421000,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "totalAssets": null,
    "bookValue": 35.972,
    "sharesShort": 1798641,
    "sharesPercentSharesOut": 0.0176,
    "fundFamily": null,
    "lastFiscalYearEnd": 1609372800,
    "heldPercentInstitutions": 0.55792,
    "netIncomeToCommon": -1300445952,
    "trailingEps": -14.174,
    "lastDividendValue": null,
    "SandP52WeekChange": null,
    "priceToBook": 6.2643166,
    "heldPercentInsiders": 0.18496999,
    "nextFiscalYearEnd": 1672444800,
    "yield": null,
    "mostRecentQuarter": 1632960000,
    "shortRatio": 6.07,
    "sharesShortPreviousMonthDate": 1636934400,
    "floatShares": 55595485,
    "beta": 0.784935,
    "enterpriseValue": 19884374016,
    "priceHint": 2,
    "threeYearAverageReturn": null,
    "lastSplitDate": null,
    "lastSplitFactor": null,
    "legalType": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": null,
    "priceToSalesTrailing12Months": 22.533066,
    "dateShortInterest": 1639526400,
    "pegRatio": -0.58,
    "ytdReturn": null,
    "forwardPE": -16.65484,
    "lastCapGain": null,
    "shortPercentOfFloat": null,
    "sharesShortPriorMonth": 2072644,
    "category": null,
    "fiveYearAverageReturn": null,
    "previousClose": 221.58,
    "regularMarketOpen": 220.58,
    "twoHundredDayAverage": 330.58624,
    "trailingAnnualDividendYield": null,
    "payoutRatio": 0,
    "volume24Hr": null,
    "regularMarketDayHigh": 229.27,
    "navPrice": null,
    "averageDailyVolume10Day": 265240,
    "regularMarketPreviousClose": 221.58,
    "fiftyDayAverage": 323.6666,
    "trailingAnnualDividendRate": null,
    "open": 220.58,
    "averageVolume10days": 265240,
    "expireDate": null,
    "algorithm": null,
    "dividendRate": null,
    "exDividendDate": null,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 220.06,
    "currency": "USD",
    "regularMarketVolume": 340747,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 23939219456,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 246659,
    "dayLow": 220.06,
    "ask": 0,
    "askSize": 800,
    "volume": 340747,
    "fiftyTwoWeekHigh": 426.56,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": null,
    "fiftyTwoWeekLow": 220.06,
    "bid": 0,
    "tradeable": false,
    "dividendYield": null,
    "bidSize": 800,
    "dayHigh": 229.27,
    "regularMarketPrice": 225.34,
    "preMarketPrice": null,
    "logo_url": "https://logo.clearbit.com/beigene.com"
}